Viking Therapeutics, Inc. reported financial results for first quarter ended March 31, 2026.
“On April 29, 2026, we issued a press release reporting our financial results for the first quarter ended March 31, 2026 and providing a corporate update.”
Viking Therapeutics, Inc. — fact timeline
Source-grounded facts extracted from Viking Therapeutics, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Viking Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2024.
“On April 24, 2024, we issued a press release reporting our financial results for the first quarter ended March 31, 2024 and providing a corporate update.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.